Allergan Voluntarily Recalls BIOCELL(R) Textured Breast Implants and Tissue Expanders
Global Action Follows Notification of Updated Safety Information from the U.S. Food and Drug Administration (FDA)
FDA Does Not Recommend Removal or Replacement of Textured Breast Implants in Asymptomatic Patients
Smooth and MICROCELL® Breast Impl... Devices, Product Recall Allergan, BIOCELL, breast implant, tissue expander
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Allergy | Breast Augmentation | Food and Drug Administration (FDA) | Pharmaceuticals | Plastic Surgery